-+ 0.00%
-+ 0.00%
-+ 0.00%

Royalty Pharma names Greg Raskin SVP, head of academic initiatives

PUBT·08/03/2026 12:15:25
Listen to the news
Royalty Pharma names Greg Raskin SVP, head of academic initiatives
  • Royalty Pharma named Greg Raskin senior vice president, head of academic initiatives, effective August 2026.
  • He will lead outreach with academic and non-profit institutions, overseeing the Royalty Pharma Translational Prize.
  • Raskin previously served as senior vice president, technology development at Memorial Sloan Kettering Cancer Center, leading tech transfer and startup formation.
  • Earlier roles include vice president at AllianceBernstein’s venture fund, biotech analyst at Baker Brothers Investments, consultant at McKinsey.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608030815PRIMZONEFULLFEED9802421) on August 03, 2026, and is solely responsible for the information contained therein.